Striatal efferent involvement and its correlation to levodopa efficacy in patients with multiple system atrophy

Neurology

Volumn 47, Issue 5, 1996, Pages 1291-1299

  Ito, Hidefumi ^a   Kusaka, Hirofumi ^a   Matsumoto, Sadayuki ^a   Imai, Terukuni ^a  

^a Kitano Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALBINDIN; DOPAMINE; LEVODOPA; METENKEPHALIN; SUBSTANCE P;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; FEMALE; GLOBUS PALLIDUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NIGRONEOSTRIATAL SYSTEM; OLIVOPONTOCEREBELLAR ATROPHY; PARKINSONISM; PRIORITY JOURNAL; SHY DRAGER SYNDROME;

EID: 0029956583     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.47.5.1291     Document Type: Article

References (46)

1. Graybiel AM, Ragsdale CW. Fiber connections of the basal ganglia. Prog Brain Res 1979;51:239-283.
2. Nauta WJH, Domesick VB. Afferent and efferent relationships of the basal ganglia. In: Evered D, O'Connor M, eds. Functions of the basal ganglia. Ciba Foundation Symposium 107. London: Pitman, 1984:3-29.
3. Evarts EV, Kimura M, Wurtz RH, Hikosaka O. Behavioral correlates of activity in basal ganglia neurons. Trends Neurosci 1984;7:447-453.
4. Albin RL, Young AB, Penney JB. The functional anatomy of basal ganglia disorders. Trends Neurosci 1989;12:366-375.
5. DeLong M. Primate models of movement disorders of basal ganglia origin. Trends Neurosci 1990;13:281-285.
6. Goto S, Hirano A, Rojas-Corona RR. Immunohistochemical visualization of afferent nerve terminals in human globus pallidus and its alteration in neostriatal neurodegenerative disorders. Acta Neuropathol (Berl) 1989;78:543-550.
7. Goto S, Hirano A, Matsumoto S. Met-enkephalin immunoreactivity in the basal ganglia in Parkinson's disease and striatonigral degeneration. Neurology 1990;40:1051-1056.
8. Goto S, Hirano A, Matsumoto S. Immunohistochemical study of the striatal efferents and nigral dopaminergic neurons in parkinsonism-dementia complex on Guam in comparison with those in Parkinson's and Alzheimer's diseases. Ann Neurol 1990;27:520-527.
9. Matsumoto S, Goto S, Hirano A. A comparative immunohistochemical study on striatal Met-enkephalin expression in Alzheimer's disease and in progressive supranuclear palsy. Acta Neuropathol (Berl) 1990;81:74-77.
10. 28k in the basal ganglia of patients with parkinsonism. Ann Neurol 1992;32:543-550.
11. Ito H, Goto S, Sakamoto S, Hirano A. Striosomal arrangement of met-enkephalin and substance P expression in parkinsonism-dementia complex on Guam. Acta Neuropathol (Berl) 1993;85:390-393.
12. Goto S, Hirano A, Rojas-Corona RR. Calcineurin immunoreactivity in striatonigral degeneration. Acta Neuropathol (Berl) 1989;78:65-71.
13. Carpenter MB, Sutin J. Human neuroanatomy. 8th ed. Baltimore: Williams and Wilkins, 1983.
14. Goto S, Hirano A, Matsumoto S. Subdivisional involvement of nigrostriatal loop in idiopathic Parkinson's disease and striatonigral degeneration. Ann Neurol 1989;26:766-770.
15. Graham JG, Oppenheimer DR. Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy. J Neurol Neurosurg Psychiatry 1969;32:28-34.
16. Celio MR. Calbindin D-28k and parvalbumin in the rat nervous system. Neuroscience 1990;35:375-475.
17. Waters CM, Peck R, Rossor M, Reynolds GP, Hunt SP. Immunocytochemical studies on the basal ganglia and substantia nigra in Parkinson's disease and Huntington's chorea. Neuroscience 1988;25:419-438.
18. Sakamoto S, Goto S, Ito H, Hirano A. Striosomal organization of substance P-like immunoreactivity in parkinsonian patients. Neurology 1992;42:1071-1075.
19. Ito H, Kusaka H, Matsumoto S, Imai T. Topographic involvement of the striatal efferents in basal ganglia of patients with adult-onset motor neuron disease with basophilic inclusions. Acta Neuropathol (Berl) 1995;89:513-518.
20. Gerfen CR, Baimbridge KG, Miller JJ. The neostriatal mosaic: compartmental distribution of calcium-binding protein and parvalbumin in the basal ganglia of the rat and monkey. Proc Natl Acad Sci USA 1985;82:8780-8784.
21. Goto S, Hirano A. Inhomogeneity of the putaminal lesion in striatonigral degeneration. Acta Neuropathol (Berl) 1990;80: 204-207.
22. Daniel SE. The neuropathology and neurochemistry of multiple system atrophy. In: Bannister R, ed. Autonomic failure. A textbook of clinical disorders of the autonomic system. 2nd ed. Oxford: Oxford University Press, 1988:564-585.
23. Papp MI, Kahn JE, Lantos PL. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J Neurol Sci 1989;94:79-100.
24. Kusaka H, Matsumoto S, Imai T. An adult-onset case of sporadic motor neuron disease with basophilic inclusions. Acta Neuropathol (Berl) 1990;80:660-665.
25. Kusaka H, Matsumoto S, Imai T. Adult-onset motor neuron disease with basophilic intraneuronal inclusion bodies. Clin Neuropathol 1993;12:215-218.
26. Izumi K, Inoue N, Shirabe T, Miyazaki T, Kuroiwa Y. Failed levodopa therapy in striato-nigral degeneration. Lancet 1971; 1:1355.
27. Bannister R, Oppenheimer DR. Degenerative diseases of the nervous system associated with autonomic failure. Brain 1972;95:457-474.
28. Rajput AH, Kazi KH, Rozdilsky B. Striatonigral degeneration response to levodopa therapy. J Neurol Sci 1972;16:331-341.
29. Lees AJ. The treatment of multiple system atrophy: striatonigral degeneration and olivopontocerebellar degeneration. In: Bannister R, ed. Autonomie failure. A textbook of clinical disorders of the autonomic system. 2nd ed. Oxford: Oxford University Press, 1988:596-604.
30. Quinn N. Multiple system atrophy - the nature of the beast. J Neurol Neurosurg Psychiatry 1989;(special suppl):78-89.
31. Lang AE, Birnbaum A, Blair RDG, Kierans C. Levodopa dose-related fluctuations in presumed olivopontocerebellar atrophy. Mov Disord 1986;1:93-102.
32. Rajput AH, Rozdilsky B, Rajput A, Ang L. Levodopa efficacy and pathological basis of parkinson syndrome. Clin Neuropharmacol 1990;13:553-558.
33. Fearnley JM, Lees AJ. Striatonigral degeneration. A clinicopathological study. Brain 1990;113:1823-1842.
34. Pascual J, Pazos A, del Olmo E, Figols J, Leno C, Berciano J. Presynaptic parkinsonism in olivopontocerebellar atrophy: clinical, pathological, and neurochemical evidence. Ann Neurol 1991;30:425-428.
35. Hughes AJ, Colosimo C, Kleedorfer B, Daniel SE, Lees AJ. The dopaminergic response in multiple system atrophy. J Neurol Neurosurg Psychiatry 1992;55:1009-1013.
36. Parati EA, Fetoni V, Geminiani GC, et al. Response to L-dopa in multiple system atrophy. Clin Neuropharmacol 1993;16: 139-144.
37. Quinn N. Multiple system atrophy. In: Marsden CD, Fahn S, eds. Movement disorders 3. Oxford: Butterworth-Heinemann, 1994:262-281.
38. Klawans HL, Zeitlin E. L-Dopa in parkinsonism associated with cerebellar dysfunction (probable olivopontocerebellar degeneration). J Neurol Neurosurg Psychiatry 1971;34:14-19.
39. Goetz CG, Tanner CM, Klawans HL. The pharmacology of olivopontocerebellar atrophy. Adv Neurol 1984;41:143-148.
40. 3H]spiperone binding in human caudate nucleus, substantia nigra and frontal cortex in the Shy-Drager syndrome and Parkinson's disease. J Neurol Sci 1979;43:429-437.
41. 2 sites in Parkinson syndrome of different etiology. Brain Res 1989;483:30-38.
42. 11C-raclopride and positron emission tomography. Ann Neurol 1992;31:184-192.
43. Shinotoh H, Inoue O, Hirayama K, et al. Dopamine D1 receptors in Parkinson's disease and striatonigral degeneration: a positron emission tomography study. J Neurol Neurosurg Psychiatry 1993;56:467-472.
44. Shimoyama M, Kito S, Itoga E, et al. Binding experiments of muscarinic acetylcholine and dopamine receptors in human brains with emphasis on a case of striatonigral degeneration. Jpn J Pharmacol 1982;32:1157-1166.
45. Graybiel AM, Ragsdale CW. Biochemical anatomy of the striatum. In: Emson PC, ed. Chemical neuroanatomy. New York: Raven, 1983:427-504.
46. Gilman S, Koeppe RA, Junck L, Kluin KJ, Lohman M, St. Laurent RT. Benzodiazepine receptor binding in cerebellar degenerations studied with positron emission tomography. Ann Neurol 1995;38:176-185.